Stay updated on Rapastinel Long-term Safety in Major Depressive Disorder Clinical Trial
Sign up to get notified when there's something new on the Rapastinel Long-term Safety in Major Depressive Disorder Clinical Trial page.

Latest updates to the Rapastinel Long-term Safety in Major Depressive Disorder Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedThe page shows a revision update from v3.3.1 to v3.3.2, with no visible changes to the study details or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check25 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.1; no study details, eligibility criteria, or outcomes appear to have changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check32 days agoChange DetectedRemoval of the government funding notice at the top of the page; all study details and navigational elements remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check46 days agoChange DetectedNo additions or deletions were observed on the Study Details page for NCT03002077; the content remains the same.SummaryDifference0.2%

- Check75 days agoChange DetectedUpdate adds an operational status notice and a new software version (v3.2.0), replacing the old v3.0.2.SummaryDifference3%

- Check76 days agoChange DetectedUpdated the page from revision v3.0.2 to v3.1.0 to reflect the new software version.SummaryDifference0.1%

Stay in the know with updates to Rapastinel Long-term Safety in Major Depressive Disorder Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rapastinel Long-term Safety in Major Depressive Disorder Clinical Trial page.